170 related articles for article (PubMed ID: 36580018)
21. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
[TBL] [Abstract][Full Text] [Related]
23. Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population.
Srivastava K; Srivastava A; Mittal B
Mol Carcinog; 2010 Jul; 49(7):684-92. PubMed ID: 20564345
[TBL] [Abstract][Full Text] [Related]
24. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population.
Marques I; Teixeira AL; Ferreira M; Assis J; Lobo F; Maurício J; Medeiros R
Mol Biol Rep; 2013 Aug; 40(8):4819-26. PubMed ID: 23645041
[TBL] [Abstract][Full Text] [Related]
25. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
[TBL] [Abstract][Full Text] [Related]
26. Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.
Sargazi S; Abghari AZ; Sarani H; Sheervalilou R; Mirinejad S; Saravani R; Eskandari E
Appl Biochem Biotechnol; 2021 Dec; 193(12):4172-4196. PubMed ID: 34463927
[TBL] [Abstract][Full Text] [Related]
27. Genetic contribution of caspase-8 variants and haplotypes to breast cancer risk and prognosis: a case-control study in Iran.
Afzaljavan F; Vahednia E; Barati Bagherabad M; Vakili F; Moezzi A; Hosseini A; Homaei Shandiz F; Kooshyar MM; Nassiri M; Pasdar A
BMC Med Genomics; 2023 Apr; 16(1):72. PubMed ID: 37016353
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
29. Single Nucleotide Polymorphisms in
Bradshaw G; Haupt LM; Aquino EM; Lea RA; Sutherland HG; Griffiths LR
Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30818878
[TBL] [Abstract][Full Text] [Related]
30. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Tong D; Cha Z; Bai J
Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
[TBL] [Abstract][Full Text] [Related]
31. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
Wang SS; Menashe I; Cerhan JR; Cozen W; Severson RK; Davis S; Hutchinson A; Rothman N; Chanock SJ; Bernstein L; Hartge P; Morton LM
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):42-9. PubMed ID: 21148756
[TBL] [Abstract][Full Text] [Related]
32. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population.
Suthandiram S; Gan GG; Zain SM; Haerian BS; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
J Hum Genet; 2014 May; 59(5):280-7. PubMed ID: 24646728
[TBL] [Abstract][Full Text] [Related]
35. Association of MTHFR C677T and A1298C polymorphisms with non-Hodgkin lymphoma susceptibility: evidence from a meta-analysis.
He J; Liao XY; Zhu JH; Xue WQ; Shen GP; Huang SY; Chen W; Jia WH
Sci Rep; 2014 Aug; 4():6159. PubMed ID: 25146845
[TBL] [Abstract][Full Text] [Related]
36. Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.
Li G; Li D
Hum Immunol; 2016 May; 77(5):418-25. PubMed ID: 27006334
[TBL] [Abstract][Full Text] [Related]
37. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.
He YQ; Zhu JH; Huang SY; Cui Z; He J; Jia WH
Tumour Biol; 2014 Dec; 35(12):12509-17. PubMed ID: 25204673
[TBL] [Abstract][Full Text] [Related]
38. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.
Zhang Y; Li W; Hong Y; Wu G; He K; Liu D
J Genet; 2017 Jun; 96(2):283-289. PubMed ID: 28674227
[TBL] [Abstract][Full Text] [Related]
39. Association of Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms with B-Cell Non-Hodgkin Lymphoma in a Cohort of Egyptians.
Abdel Rahman HA; Khorshied MM; Reda Khorshid OM; Mourad HM
Turk J Haematol; 2018 May; 35(2):99-108. PubMed ID: 28713071
[TBL] [Abstract][Full Text] [Related]
40. LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: a systematic review and pooled analysis.
Lin HY; Shi H; Li CY; Chen QC; Huang TB; Liu PC; Lou LM
J BUON; 2015; 20(1):261-8. PubMed ID: 25778326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
